We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Exploring Analyst Estimates for Altria (MO) Q2 Earnings, Beyond Revenue and EPS
Read MoreHide Full Article
Wall Street analysts forecast that Altria (MO - Free Report) will report quarterly earnings of $1.37 per share in its upcoming release, pointing to a year-over-year increase of 4.6%. It is anticipated that revenues will amount to $5.19 billion, exhibiting a decrease of 1.6% compared to the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.5% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some Altria metrics that Wall Street analysts commonly model and monitor.
The consensus among analysts is that 'Net revenue- All Other/ Financial Services' will reach $14.00 million. The estimate indicates a change of +366.7% from the prior-year quarter.
According to the collective judgment of analysts, 'Revenues net of excise taxes- Oral tobacco products' should come in at $701.72 million. The estimate indicates a change of +2.1% from the prior-year quarter.
Analysts forecast 'Revenues net of excise taxes- Smokeable Products' to reach $4.43 billion. The estimate suggests a change of -3.3% year over year.
The average prediction of analysts places 'Operating Income (Loss)/ Reported OCI- Oral tobacco products' at $459.60 million. Compared to the current estimate, the company reported $97.00 million in the same quarter of the previous year.
The combined assessment of analysts suggests that 'Adjusted OCI- Smokeable Products' will likely reach $2.86 billion. Compared to the current estimate, the company reported $2.83 billion in the same quarter of the previous year.
Shares of Altria have demonstrated returns of +1.4% over the past month compared to the Zacks S&P 500 composite's +4.6% change. With a Zacks Rank #3 (Hold), MO is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Exploring Analyst Estimates for Altria (MO) Q2 Earnings, Beyond Revenue and EPS
Wall Street analysts forecast that Altria (MO - Free Report) will report quarterly earnings of $1.37 per share in its upcoming release, pointing to a year-over-year increase of 4.6%. It is anticipated that revenues will amount to $5.19 billion, exhibiting a decrease of 1.6% compared to the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.5% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some Altria metrics that Wall Street analysts commonly model and monitor.
The consensus among analysts is that 'Net revenue- All Other/ Financial Services' will reach $14.00 million. The estimate indicates a change of +366.7% from the prior-year quarter.
According to the collective judgment of analysts, 'Revenues net of excise taxes- Oral tobacco products' should come in at $701.72 million. The estimate indicates a change of +2.1% from the prior-year quarter.
Analysts forecast 'Revenues net of excise taxes- Smokeable Products' to reach $4.43 billion. The estimate suggests a change of -3.3% year over year.
The average prediction of analysts places 'Operating Income (Loss)/ Reported OCI- Oral tobacco products' at $459.60 million. Compared to the current estimate, the company reported $97.00 million in the same quarter of the previous year.
The combined assessment of analysts suggests that 'Adjusted OCI- Smokeable Products' will likely reach $2.86 billion. Compared to the current estimate, the company reported $2.83 billion in the same quarter of the previous year.
View all Key Company Metrics for Altria here>>>Shares of Altria have demonstrated returns of +1.4% over the past month compared to the Zacks S&P 500 composite's +4.6% change. With a Zacks Rank #3 (Hold), MO is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .